Showing papers by "Robert A. Balk published in 2013"
Centers for Disease Control and Prevention1, Harvard University2, Rush University Medical Center3, Society of Critical Care Medicine4, University of Virginia5, University of Pennsylvania6, University of Iowa7, University of Rochester8, Medical College of Wisconsin9, Veterans Health Administration10, National Institutes of Health11, American Association for Respiratory Care12, Tufts University13, Washington University in St. Louis14, Brown University15, Infectious Diseases Society of America16, Texas A&M University17, New York State Department of Health18, Council of State and Territorial Epidemiologists19, United States Department of Health and Human Services20
TL;DR: Ventilator-associated events surveillance was implemented in January 2013 in the CDC’s National Healthcare Safety Network and can identify a broad range of conditions and complications occurring in mechanically ventilated adult patients, including but not limited to VAP.
Abstract: Objective:To develop and implement an objective, reliable approach to surveillance for ventilator-associated events in adult patients.Design:The Centers for Disease Control and Prevention (CDC) convened a Ventilator-Associated Pneumonia (VAP) Surveillance Definition Working Group in September 2011.
186 citations
Centers for Disease Control and Prevention1, Harvard University2, Brigham and Women's Hospital3, American College of Chest Physicians4, Rush University Medical Center5, University of Virginia6, University of Pennsylvania7, Roy J. and Lucille A. Carver College of Medicine8, University of Rochester9, Medical College of Wisconsin10, Veterans Health Administration11, National Institutes of Health12, American Association for Respiratory Care13, Tufts Medical Center14, Washington University in St. Louis15, Brown University16, Texas A&M Health Science Center17, Infectious Diseases Society of America18, Council of State and Territorial Epidemiologists19, New York State Department of Health20, United States Department of Health and Human Services21, Johns Hopkins University School of Medicine22
TL;DR: This book presents a meta-analyses of the immune system’s response to certain types of infectious disease, called “hallucinations,” which have an uncertain prognosis and can be treated with antibiotics.
Abstract: Shelley S Magill MD PhD, Michael Klompas MD MPH, Robert Balk MD, Suzanne M Burns RN ACNP MSN RRT, Clifford S Deutschman MS MD, Daniel Diekema MD, Scott Fridkin MD, Linda Greene RN MPS, Alice Guh MD MPH, David Gutterman MD, Beth Hammer RN MSN ANP-BC, David Henderson MD, Dean R Hess PhD RRT, Nicholas S Hill MD, Teresa Horan MPH, Marin Kollef MD, Mitchell Levy MD, Edward Septimus MD, Carole VanAntwerpen RN BSN, Don Wright MD MPH, and Pamela Lipsett MD MHPE
70 citations
Scott & White Hospital1, Rush University Medical Center2, University of Kansas3, Primary Children's Hospital4, University of Medicine and Dentistry of New Jersey5, University of Colorado Denver6, Texas Tech University Health Sciences Center7, Memorial Hospital of South Bend8, Baylor College of Medicine9, University of Pittsburgh10, Brown University11, Loma Linda University12, University of Texas MD Anderson Cancer Center13, Saint Louis University14, Houston Methodist Hospital15, University of California, Los Angeles16, Duke University17, Wake Forest University18, University of California, Davis19, Henry Ford Health System20, University of Iowa21, George Washington University22, Tufts University23, St. John's University24
TL;DR: Enteral administration of talactoferrin reduced 28-day all-cause mortality in patients with severe sepsis and this reduction was sustained at 6 months, meeting the protocol-specified primary endpoint.
Abstract: Objectives:Lactoferrin is a glycoprotein with anti-infective and anti-inflammatory properties found in secretions and immune cells. Talactoferrin alfa, a recombinant form of human lactoferrin, has similar properties and plays an important role in maintaining the gastrointestinal mucosal barrier inte
68 citations
Centers for Disease Control and Prevention1, Brigham and Women's Hospital2, American College of Chest Physicians3, University of Pennsylvania4, Roy J. and Lucille A. Carver College of Medicine5, University of Rochester6, National Institutes of Health7, American Association for Respiratory Care8, Infectious Diseases Society of America9, Council of State and Territorial Epidemiologists10, United States Department of Health and Human Services11, Johns Hopkins University School of Medicine12
TL;DR: This book presents a meta-analyses of the immune system’s response to certain types of infectious disease, called “hallucinations,” which have an uncertain prognosis and can be treated with antibiotics.
38 citations
Centers for Disease Control and Prevention1, Harvard University2, Rush University Medical Center3, University of Virginia4, University of Pennsylvania5, University of Iowa6, University of Rochester7, Medical College of Wisconsin8, United States Department of Veterans Affairs9, National Institutes of Health10, Tufts University11, Washington University in St. Louis12, Society of Critical Care Medicine13, Brown University14, Texas A&M University15, New York State Department of Health16, United States Department of Health and Human Services17, Johns Hopkins University18
TL;DR: This article is an executive summary of a report from the Centers for Disease Control and Prevention Ventilator-Associated Pneumonia Surveillance Definition Working Group, entitled "Developing a New, National approach to Surveillance for VentilATOR-Associatied Events".
Abstract: This article is an executive summary of a report from the Centers for Disease Control and Prevention Ventilator-Associated Pneumonia Surveillance Definition Working Group, entitled "Developing a New, National Approach to Surveillance for Ventilator-Associatied Events," published in Critical Care Medicine, by Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, et al. 2013;41(11):2467-2475. The full report provides a comprehensive description of the Working Group's process and outcome.
27 citations
Centers for Disease Control and Prevention1, Harvard University2, Society of Critical Care Medicine3, Rush University Medical Center4, University of Virginia5, University of Pennsylvania6, University of Iowa7, University of Rochester8, Medical College of Wisconsin9, Veterans Health Administration10, National Institutes of Health11, American Association for Respiratory Care12, Tufts University13, Washington University in St. Louis14, Brown University15, Texas A&M University16, Infectious Diseases Society of America17, New York State Department of Health18, Council of State and Territorial Epidemiologists19, United States Department of Health and Human Services20, American College of Chest Physicians21
TL;DR: This article is an executive summary of a report from the Centers for Disease Control and Prevention Ventilator-Associated Pneumonia Surveillance Definition Working Group, entitled “Developing a new, national approach to surveillance for ventilATOR-associated events” and published in Critical Care Medicine.
Abstract: This article is an executive summary of a report from the Centers for Disease Control and Prevention Ventilator-Associated Pneumonia Surveillance Definition Working Group, entitled “Developing a new, national approach to surveillance for ventilator-associated events” and published in Critical Care Medicine. The full report provides a comprehensive description of the Working Group process and outcome.In September 2011, the Centers for Disease Control and Prevention (CDC) convened a Ventilator-Associated Pneumonia (VAP) Surveillance Definition Working Group to organize a formal process for leaders and experts of key stakeholder organizations to discuss the challenges of VAP surveillance definitions and to propose new approaches to VAP surveillance in adult patients (Table 1).
13 citations
Centers for Disease Control and Prevention1, Harvard University2, Society of Critical Care Medicine3, Rush University Medical Center4, University of Virginia5, University of Pennsylvania6, University of Iowa7, University of Rochester8, Medical College of Wisconsin9, Veterans Health Administration10, National Institutes of Health11, American Association for Respiratory Care12, Tufts University13, Washington University in St. Louis14, Brown University15, Infectious Diseases Society of America16, Texas A&M University17, Council of State and Territorial Epidemiologists18, New York State Department of Health19, United States Department of Health and Human Services20
12 citations
Centers for Disease Control and Prevention1, Harvard University2, Brigham and Women's Hospital3, Rush University Medical Center4, American College of Chest Physicians5, University of Virginia6, University of Pennsylvania7, Roy J. and Lucille A. Carver College of Medicine8, University of Rochester9, Medical College of Wisconsin10, Veterans Health Administration11, National Institutes of Health12, American Association for Respiratory Care13, Tufts Medical Center14, Washington University in St. Louis15, Brown University16, Infectious Diseases Society of America17, Texas A&M Health Science Center18, Council of State and Territorial Epidemiologists19, New York State Department of Health20, United States Department of Health and Human Services21, Johns Hopkins University School of Medicine22
TL;DR: A draft, streamlined VAP surveillance definition developed for use in adult patients is critically reviewed and a final adult surveillance definition algorithm to be implemented in the CDC's National Healthcare Safety Network (NHSN), taking into consideration the potential future use of the definition algorithm in public reporting, interfacility comparisons, and pay-for-reporting and pay for-performance programs.
8 citations
Centers for Disease Control and Prevention1, Brigham and Women's Hospital2, Harvard University3, Rush University Medical Center4, American College of Chest Physicians5, University of Virginia6, University of Pennsylvania7, Roy J. and Lucille A. Carver College of Medicine8, University of Rochester9, Medical College of Wisconsin10, Veterans Health Administration11, National Institutes of Health12, American Association for Respiratory Care13, Tufts Medical Center14, Washington University in St. Louis15, Brown University16, Texas A&M Health Science Center17, Infectious Diseases Society of America18, New York State Department of Health19, Council of State and Territorial Epidemiologists20, United States Department of Health and Human Services21, Johns Hopkins University School of Medicine22
TL;DR: In September 2011, the Centers for Disease Control and Prevention convened a Ventilator-Associated Pneumonia Surveillance Definition Working Group to organize a formal process for leaders and experts of key stakeholder organizations to discuss the challenges of VAP surveillance.
Abstract: In September 2011, the Centers for Disease Control and Prevention (CDC) convened a Ventilator-Associated Pneumonia (VAP) Surveillance Definition Working Group to organize a formal process for leaders and experts of key stakeholder organizations to discuss the challenges of VAP surveillance
3 citations